Fig. 4.

SCC74A and SCC74B showed different responses to metabolic treatments. (a), (b) In response to rotenone and FCCP treatment, SCC74B showed greater response in NAD(P)H binding activity, as shown through NAD(P)H mean lifetime and bound NAD(P)H fraction. (c) Meanwhile, SCC74A regulated NAD(P)H intensity, and hence, concentration. Error bars represent the SEM for 30 to 50 fields of view taken for each treatment from 6 (SCC74A) and 7 (SCC74B) replicates (*$p<0.05$; **$p<0.01$; ***$p<0.001$; ****$p<0.0001$ by factorial ANOVA and Tukey post hoc test).